TILMICON-300

solution for injection
tilmicosin 30%

TILMICON-300

Transparent liquid of yellow to light-brown color

CattleSheep
TILMICON-300
10 ml
100 ml

Composition

1 ml of preparation contains active substance:

Tilmicosin – 300 mg;

Excipients: benzyl alcohol, propylene glycol, water for injection.

Pharmacological properties

АТС vet QJ01 – antibacterial veterinary drugs for systemic use. QJ01FA91 – Tilmicosin.

Tilmicosin is a semi-synthetic antibiotic of the macrolide group, which has bacteriostatic effect in low concentrations and a bactericidal effect in high concentrations, mainly on Gram-positive microorganisms and some Gram-negative microorganisms and mycoplasmas, such as Mannheimia spp., Pasteurella spp., Actinomyces spp., Fusobacterium spp., Dichelobacter spp., Staphylococcus spp., and Mycoplasma spp. as well.

Tilmicosin acts at the ribosomal level (50S-subunit); it inhibits protein synthesis in the bacterial cell. Tilmicosin has lipotropic properties, due to which it easily penetrates into organs and tissues, reaching high intracellular concentrations. This property allows you to effectively deal with respiratory diseases of animals.

Tilmicosin reaches a maximum level in the blood 1 hour after a single subcutaneous injection of a dose of 10 mg per kg of animal body weight (1 ml of Tilmicon-300 per 30 kg b.w.). A high therapeutic concentration in the tissues of the body is retained for 3 days. Tilmicosin is concentrated in the lung tissue, penetrating intracellularly into alveolar macrophages. It is excreted from the body mainly with bile, and a small amount with urine.

Administration

Treatment of cattle and sheep with interdigital necrobacillosis, hoof rot (caused by Dichelobacter nodosus and Fusobacterium necrophorum), acute mastitis (caused by Staphylococcus aureus and Mycoplasma agalactiae), as well as with respiratory diseases caused by Mannheimia haemolytica, Pasteurella multocida, and other pathogens susceptible to Tilmicosin.

Route of administration and dosages

Subcutaneously – once at a dose of 1 ml of the drug per 30 kg of animal body weight (10 mg of tilmicosin per kg b.w.).

Draw up the required dose of the drug from the vial into the syringe and disconnect the syringe from the needle, leaving the needle in the vial. If the treatment of a group of animals is planned, the needle must be left in a vial to draw the drug for subsequent injections. Fix the animal and insert another, separate needle subcutaneously, behind the scapula. Connect the syringe to the needle and inject the drug into the base of the skin fold.

When using the drug in lambs, it is important to accurately control body weight in order to avoid an overdose.

If the dose of the injected drug exceeds 20 ml for cattle or 2 ml for sheep, it should be divided and injected into some different places.

Contraindications

The drug is not administered to animals with hypersensitivity to Tilmicosin or to other components of the drug.

Do not administer intravenously or intramuscularly.

Do not administer to lambs weighing less than 15 kg.

Do not administer to primates, pigs, horses, donkeys, and goats.

Precautions

Side effects

Slight swelling may occur at the injection site, which does not require treatment and disappears within 5-8 days. In rare cases, a decrease in body weight, impaired coordination, and convulsions can be observed.

Administration during pregnancy, lactation

The safety of the drug during pregnancy has not been established. The drug should be used with an assessment of the benefit/risk ratio by the responsible veterinarian.

Interaction with other drugs and other forms of interaction

At simultaneous administration with other macrolides and lincomycin, cross-resistance can be observed.

Withdrawal period

Slaughter of the animals for meat is allowed in 70 days (cattle), and in 42 days (sheep) after the last treatment. Milk for human consumption is allowed in 36 days (cattle) and in 18 days (sheep) after the last treatment. Meat and milk received before the specified time should be disposed or fed to non-productive animals, depending on the conclusion of the veterinarian.

Special precautions for persons and service staff that use the product

Strictly follow the generally accepted rules of aseptic, personal hygiene, and safetywhen working with veterinary drugs, namely:

  • the drug should be injected to animals only by a veterinarian;
  • never move the syringe, filled with the drug, together with a needle. The needle should be joined to the syringe only to fill or inject it. The rest of the time you should keep the syringe and needle in separate places;
  • do not use automatic devices to inject the drug;
  • do not carry out any manipulations with the drug yourself (alone).

The drug is toxic to the cardiovascular system when injected into humans. Toxicity is manifested due to blockade of membrane calcium channels. If the drug was entered into any person by accident, you must immediately consult a doctor, take the bottle, box, or leaflet with you. Apply a cold compress (except ice) on the injection site. Avoid contact with eyes and skin. After using the drug, wash your hands thoroughly.

Packaging and presentation

Glass vials closed with rubber stoppers under aluminum caps of 10, 50 and 100 ml.

Storage conditions

Store in a dark places, out of the reach of children, at +5 to +25°.

Shelf life

24 months. Once the vial is opened: 28 days if stored in a dark place at +5 to +25° С.